TME PHARMA NV (ALTME.PA) Stock Earnings & Estimates
EPA:ALTME - NL0015000YE1 - Common Stock
0.1026 EUR
0 (-1.54%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30K | 40K 33.33% | 80K 100.00% | 343.33K -100.00% | N/A | 20.6K | |||||||||
| EBITDA YoY % growth | -11.79M | -9.9M 16.03% | -5.8M 41.41% | -5.15M 18.97% | N/A 2.13% | -5.116M 12.61% | N/A -43.28% | -14.42M -132.47% | -28.84M 10.96% | -12.36M 60.78% | -5.614M 10.20% | -14.42M -243.42% | -18.849M -30.71% | 19.055M 201.09% | |
| EBIT YoY % growth | -12.07M | -10.12M 16.16% | -6.14M 39.33% | -4.697M 22.96% | -5.047M 2.33% | 161.37K 11.90% | N/A -43.00% | -14.42M -131.27% | -28.84M 10.74% | -12.36M 59.88% | -5.665M 11.27% | -927K 78.33% | -12.978M -1,300.00% | 56.65M 536.51% | |
| Operating Margin | -40,233.33% | -25,300.00% | -7,675.00% | -1,368.01% | N/A | N/A | N/A | N/A | N/A | N/A | -27,500.00% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -218.36 64.07% | -105.06 51.89% | 91.67 187.25% | -159.65 -274.16% | -26.78 83.23% | -22.54 15.85% | -1.02 95.48% | -0.29 71.21% | -0.03 89.47% | -0.15 -400.00% | 0.47 406.67% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 93.62% | 93.62% |
| Revenue | N/A | N/A | N/A | -100% |